Finder Award
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Urovant Sciences is a biotechnology business based in the US. Urovant Sciences shares (UROV) are listed on the NASDAQ and all prices are listed in US Dollars. Urovant Sciences employs 70 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Urovant Sciences stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – UROV. It's that simple.
Finder Award
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Urovant Sciences stock price (NASDAQ: UROV)
Use our graph to track the performance of UROV stocks over time.Urovant Sciences shares at a glance
Information last updated 2021-05-23.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $16.21 |
| 200-day moving average | $13.98 |
| Wall St. target price | $16.17 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-3.92 |
Buy Urovant Sciences stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.1 - 5 of 5
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Urovant Sciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Urovant Sciences financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -75.13% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | $0.78 |
| Market capitalisation | $531.8 million |
TTM: trailing 12 months
Urovant Sciences share dividends
We're not expecting Urovant Sciences to pay a dividend over the next 12 months.
Urovant Sciences share price volatility
Over the last 12 months, Urovant Sciences's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Urovant Sciences's is 2.3354. This would suggest that Urovant Sciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Urovant Sciences overview
Urovant Sciences Ltd. , a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for urologic conditions in the United States. The company's lead product candidate is vibegron, an oral small molecule beta-3 agonist for the treatment of overactive bladder (OAB), OAB in men with benign prostatic hyperplasia, and abdominal pain due to irritable bowel syndrome. It is also developing URO-902, a gene therapy for patients with OAB who have failed oral pharmacological therapy. The company was formerly known as Thalavant Sciences Ltd. and changed its name to Urovant Sciences Ltd. in January 2017.
Frequently asked questions
What percentage of Urovant Sciences is owned by insiders or institutions?Currently 71.346% of Urovant Sciences shares are held by insiders and 19.213% by institutions. How many people work for Urovant Sciences?
Latest data suggests 70 work at Urovant Sciences. When does the fiscal year end for Urovant Sciences?
Urovant Sciences's fiscal year ends in March. Where is Urovant Sciences based?
Urovant Sciences's address is: 11-12 Street, James?s Square, London, United Kingdom, SW1Y 4LB What is Urovant Sciences's ISIN number?
Urovant Sciences's international securities identification number is: BMG9381B1081 What is Urovant Sciences's CUSIP number?
Urovant Sciences's Committee on Uniform Securities Identification Procedures number is: G9381B108
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert